Gazing into the future – what will the next 100 years of diabetes innovation look like? A perspective from industry

Authors

  • Zoe Cholewa Dexcom

DOI:

https://doi.org/10.15277/bjd.2022.375

Keywords:

Real time Continuous Glucose Monitoring, CGM, rt-CGM, Dexcom

References

Type 1 diabetes technology: a consensus guideline. https://digital.nhs.uk/ data-and-information/publications/statistical/national-diabetes-audit/na- tional-diabetes-audit-2019-20-type-1-diabetes.

Dexcom. Simon-Kucher & Partners. HCP discussions, November 2021.

Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.

Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/ guidance/ng18.

Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.

Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and intermit- tently scanned continuous glucose monitoring in adults with type 1 dia- betes (ALERTT1): a 6-month, prospective, multicentre randomised controlled trial. Lancet 2021;397(10291):2275–2283. https://doi.org/10.1016/S0140-6736(21)00789-3

Downloads

Published

2022-12-22

Issue

Vol. 22 No. Supplement 1 (2022): December 2022 Supplement 1

Section

Supplement

License

Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.